跳至主要内容
临床试验/JPRN-jRCT2080220117
JPRN-jRCT2080220117未知Unknown

A feasibility study of Oxaliplatin(L-OHP)in combination with infusional 5-FU/l-LV(FOLFOX4 regimen)for advanced colorectal cancer

Yakult Honsha Co.,Ltd.0 个研究点开始时间: 2005年9月12日最近更新:
适应症

试验速览

阶段
Unknown

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)

入选标准

  • Histologically proven colorectal cancer
  • Unresectable and advanced colorectal cancer
  • Age is older than 20 years old
  • Performance Status (ECOG scale):0-1

排除标准

  • 未提供

研究者

相似试验

已完成
1 期
Phase I/II study of the combination of Oxaliplatin and S-1 in patients with advanced/recurrent colorectal cancerunresectable advanced/recurrent colorectal cancer
JPRN-C000000443Outpatient Oncology Unit Kyoto University Hospital42
进行中(未招募)
不适用
Phase I/II study of oxaliplatin combined with melphalan in isolated hepatic perfusion for the treatment of liver metastases. - Oxaliplatin combined with melphalan in IHP.
EUCTR2006-005088-25-NLeiden University Medical Center
尚未招募
不适用
Phase I/II study of oxaliplatin combined with melphalan in isolated hepatic perfusion for the treatment of liver metastases.liver metastasessecondary liver tumours10017991
NL-OMON30309eids Universitair Medisch Centrum60
终止
2 期
Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung CancerSmall Cell Lung Cancer
NCT00316433Swedish Medical Center24
已完成
1 期
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasChildhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell LymphomaChildhood Grade III Lymphomatoid GranulomatosisChildhood Immunoblastic Large Cell LymphomaRecurrent Childhood Brain Stem GliomaRecurrent Childhood Cerebellar AstrocytomaRecurrent Childhood Cerebral AstrocytomaRecurrent Childhood EpendymomaRecurrent Childhood Grade III Lymphomatoid GranulomatosisRecurrent Childhood Large Cell LymphomaRecurrent Childhood Liver CancerRecurrent Childhood Lymphoblastic LymphomaRecurrent Childhood Malignant Germ Cell TumorRecurrent Childhood MedulloblastomaRecurrent Childhood RhabdomyosarcomaRecurrent Childhood Small Noncleaved Cell LymphomaRecurrent Childhood Soft Tissue SarcomaRecurrent Childhood Supratentorial Primitive Neuroectodermal TumorRecurrent Childhood Visual Pathway GliomaRecurrent Colon CancerRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent MelanomaRecurrent Nasopharyngeal CancerRecurrent NeuroblastomaRecurrent OsteosarcomaRecurrent Wilms Tumor and Other Childhood Kidney TumorsRecurrent/Refractory Childhood Hodgkin LymphomaUnspecified Childhood Solid Tumor, Protocol Specific
NCT00101270National Cancer Institute (NCI)24